Recurrent liver failure caused by IgG4 associated cholangitis

Annals of Hepatology

Volumn 10, Issue 4, 2011, Pages 562-564

  Clendenon, Jacob N ^a   Aranda Michel, Jaime ^a   Krishna, Murli ^a   Taner, C Burcin ^a   Willingham, Darrin L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoimmune cholangitis; Autoimmune diseases; Bile duct diseases; Immunoglobulin G4

Indexed keywords

IMMUNOGLOBULIN G4; PREDNISONE;

ADULT; ARTICLE; ASCITES; BACTEREMIA; BILE DUCT INJURY; CASE REPORT; CHOLANGITIS; CHRONIC PANCREATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; END STAGE LIVER DISEASE; FATIGUE; FEMALE; GRAFT FAILURE; HEPATIC ENCEPHALOPATHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN G4 ASSOCIATED CHOLANGITIS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTRAHEPATIC BILE DUCT; JAUNDICE; LIVER BIOPSY; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PANCREAS CANCER; PANCREATICODUODENECTOMY; PERCUTANEOUS DRAINAGE; PERIPHERAL EDEMA; PRIMARY SCLEROSING CHOLANGITIS; RECURRENT DISEASE; RETRANSPLANTATION; SEPSIS;

EID: 80052716058     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31527-3     Document Type: Article

References (12)

1. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40(7): 1561-8.
2. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344(10): 732-8.
3. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, Okamoto A, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38(10): 982-4.
4. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 2006; 41(7): 982-4.
5. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 2008; 14(25): 3948-55.
6. Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, Chari S, et al. Elevated Serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006; 4: 1010-6.
7. Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 2010; 45(5): 471-7.
8. Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A, Okumura F, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009; 58(11): 1504-7.
9. Björnsson E, Chari ST, Smyrk TC, Lindor K. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 2007; 45(6): 1547-54.
10. Toosi MN, Heathcote J. Pancreatic pseudotumor with sclerosing pancreato-cholangitis: is this a systemic disease? Am J Gastroenterol 2004; 99: 377-82.
11. Kamisawa T, et al. Sclerosing cholangitis associated with autoimmune pancreatitis differs from primary sclerosing cholangitis. World J Gastroenterol 2009; 15(19): 2357-60.
12. Prasad P, Salem RR, Mangla R, Aslanian H, Jain D, Lee J. Lymphoplasmacytic sclerosing pancreato-cholangitis: a case report and review of the literature. Yale J Biol Med 2004; 77: 143-8.